S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cheryl L. Willman, MD
University of New Mexico Cancer Center
Study Chair - Jeffrey E. Lancet, MD
H. Lee Moffitt Cancer Center and Research Institute
Study Chair - Marilyn L. Slovak, PhD
City of Hope Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
192 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sutter Cancer Center at Roseville Medical Center
Roseville, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Stanford Cancer Center
Stanford, California, United States
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- M.D. Anderson Cancer Center at Orlando
Orlando, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
- Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
Boise, Idaho, United States
- Hematology and Oncology Associates
Chicago, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Kellogg Cancer Care Center
Highland Park, Illinois, United States
- Provena St. Mary'S Regional Cancer Center - Kankakee
Kankakee, Illinois, United States
- North Shore Oncology and Hematology Associates, Limited - Libertyville
Libertyville, Illinois, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- Cancer Care and Hematology Specialists of Chicagoland - Niles
Niles, Illinois, United States
- Swedish-American Regional Cancer Center
Rockford, Illinois, United States
- Hematology Oncology Associates - Skokie
Skokie, Illinois, United States
- Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
- Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
- Siouxland Hematology-Oncology Associates, Llp
Sioux City, Iowa, United States
- St. Luke'S Regional Medical Center
Sioux City, Iowa, United States
- Cancer Center of Kansas, Pa - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas, Pa - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, Pa - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas - Fort Scott
Fort Scott, Kansas, United States
- Cancer Center of Kansas-Independence
Independence, Kansas, United States
- Providence Medical Center
Kansas City, Kansas, United States
- Cancer Center of Kansas, Pa - Kingman
Kingman, Kansas, United States
- Lawrence Memorial Hospital
Lawrence, Kansas, United States
- Cancer Center of Kansas, Pa - Liberal
Liberal, Kansas, United States
- Cancer Center of Kansas, Pa - Mcpherson
McPherson, Kansas, United States
- Cancer Center of Kansas, Pa - Newton
Newton, Kansas, United States
- Menorah Medical Center
Overland Park, Kansas, United States
- Saint Luke'S Hospital - South
Overland Park, Kansas, United States
- Cancer Center of Kansas, Pa - Parsons
Parsons, Kansas, United States
- Ccop - Kansas City
Prairie Village, Kansas, United States
- Cancer Center of Kansas, Pa - Pratt
Pratt, Kansas, United States
- Cancer Center of Kansas, Pa - Salina
Salina, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2007
- Primary completion
- 1 Jun 2017
- Completion
- 5 Feb 2018
- Last update posted
- 10 Jan 2023
- Registered enrollment
- 78
- Registry id
- NCT00551460
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.